Ja. Vinson et Tb. Howard, INHIBITION OF PROTEIN GLYCATION AND ADVANCED GLYCATION END-PRODUCTS BY ASCORBIC-ACID AND OTHER VITAMINS AND NUTRIENTS, Journal of nutritional biochemistry, 7(12), 1996, pp. 659-663
Nonenzymatic glycation, the reaction of glucose and other reducing sug
ars with protein, reversibly produces Amadori products and over a long
period irreversible advanced glycation end products. In diabetes, the
se reactions are greatly accelerated and are important in the pathogen
esis of diabetic complications. In vitro glycation was studied with bo
vine albumin as the model protein. A mixture of 25 mM glucose/fructose
was used as the glycating agent. The Amadori product was quantitated
by thiobarbituric acid colorimetry after hydrolysis. Advanced glycatio
n endproducts were measured by their intrinsic fluorescence. A number
of vitamins and nutrients were found to be potent inhibitors of both t
he glycation reaction and the subsequent end products. The nutrients w
ere effective at physiological concentrations and exhibited dose-respo
nse relationships. The inhibitors included ascorbic acid, tocopherol,
pyridoxal, niacinamide, sodium selenite, selenium yeast, and carnosine
. A significant correlation was found between the inhibition of glycat
ion and the inhibition of AGE formation (P <0.001). One of the nutrien
ts, ascorbic acid, was used in a pilot study. Eighteen normal subjects
, 7 college age and 10 middle age, were supplemented with 1,000 mg of
ascorbic acid in the form of Re-Natured Vitamin C(R) for a period of 4
weeks. Serum protein glycation was decreased an average of 46.8% (P <
0.01). These results underline the importance of nutrition in diabetes
and indicate the possibility of therapeutic use of these nutrients fo
r the prevention of diabetic complications. (C) Elsevier Science Inc.
1996